157 related articles for article (PubMed ID: 14752227)
1. Clinical implications of alpha-fetoprotein expression in gastric adenocarcinoma.
Chen J; Röcken C; Treiber G; Jentsch-Ulrich K; Malfertheiner P; Ebert MP
Dig Dis; 2003; 21(4):357-62. PubMed ID: 14752227
[TBL] [Abstract][Full Text] [Related]
2. Gastric hepatoid adenocarcinoma and familial investigation: does it always produce alpha-fetoprotein?
Trompetas V; Varsamidakis N; Frangia K; Polimeropoulos V; Kalokairinos E
Eur J Gastroenterol Hepatol; 2003 Nov; 15(11):1241-4. PubMed ID: 14560160
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features of gastric cancers producing alpha-fetoprotein.
Kono K; Amemiya H; Sekikawa T; Iizuka H; Takahashi A; Fujii H; Matsumoto Y
Dig Surg; 2002; 19(5):359-65; discussion 365. PubMed ID: 12435906
[TBL] [Abstract][Full Text] [Related]
4. Hepatoid adenocarcinoma of the stomach: case report and short notes on immunohistochemical markers.
Augustin G; Jelincic Z; Tentor D; Majerovic M; Matosevic P
Acta Gastroenterol Belg; 2009; 72(2):253-6. PubMed ID: 19637784
[TBL] [Abstract][Full Text] [Related]
5. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
[TBL] [Abstract][Full Text] [Related]
6. Evidence for hepatocellular differentiation in alpha-fetoprotein-negative gastric adenocarcinoma with hepatoid morphology: a study with in situ hybridisation for albumin mRNA.
Supriatna Y; Kishimoto T; Uno T; Nagai Y; Ishikura H
Pathology; 2005 Jun; 37(3):211-5. PubMed ID: 16175893
[TBL] [Abstract][Full Text] [Related]
7. [AFP-producing adenocarcinoma of the stomach. A rare tumor with poor prognosis].
Kaiser U; Zugmaier G; Frank M; Riedel I; Neubauer A; Moll R
Pathologe; 2003 Mar; 24(2):141-5. PubMed ID: 12673505
[TBL] [Abstract][Full Text] [Related]
8. c-Met expression in a gastric cancer cell line producing alpha-fetoprotein.
Amemiya H; Kono K; Takahashi A; Kamei S; Sugai H; Ichihara F; Fujii H; Matsumoto Y
Surg Today; 2004; 34(2):115-22. PubMed ID: 14745610
[TBL] [Abstract][Full Text] [Related]
9. A rare case of recurrent alpha-fetoprotein-producing gastric cancer without re-elevation of serum AFP.
Tomiyama K; Takahashi M; Fujii T; Kunisue H; Kanaya Y; Maruyama S; Yokoyama N; Shimizu N; Soda M
J Int Med Res; 2006; 34(1):109-14. PubMed ID: 16604831
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical presentation of alpha-fetoprotein-producing gastric cancer in ascitic fluid: a case study.
Kobayashi TK; Gotoh T; Kamachi M; Watanabe S; Sawaragi I
Diagn Cytopathol; 1988; 4(2):116-20. PubMed ID: 2468461
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation of GATA4 expression by histone modification in AFP-producing gastric adenocarcinoma.
Yamamura N; Kishimoto T
Exp Mol Pathol; 2012 Aug; 93(1):35-9. PubMed ID: 22472323
[TBL] [Abstract][Full Text] [Related]
12. Salvage surgery after chemotherapy with S-1 plus cisplatin for α-fetoprotein-producing gastric cancer with a portal vein tumor thrombus: a case report.
Nakao S; Nakata B; Tendo M; Kuroda K; Hori T; Inaba M; Hirakawa K; Ishikawa T
BMC Surg; 2015 Jan; 15(1):5. PubMed ID: 25591731
[TBL] [Abstract][Full Text] [Related]
13. An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer.
Liu X; Sheng W; Wang Y
J Surg Oncol; 2012 Sep; 106(3):299-303. PubMed ID: 22389029
[TBL] [Abstract][Full Text] [Related]
14. Double cancer of the stomach, one AFP-producing tumor.
Hyodo T; Kawamoto R
J Gastroenterol; 1996 Dec; 31(6):851-4. PubMed ID: 9027651
[TBL] [Abstract][Full Text] [Related]
15. A case of alpha-fetoprotein-producing gastric cancer.
Foo KF; Tan CK; Wong KK; Hong GS; Ngan BY
Ann Acad Med Singap; 2001 Jan; 30(1):58-61. PubMed ID: 11242628
[TBL] [Abstract][Full Text] [Related]
16. Both the serum AFP test and AFP/GPC3/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinoma.
Wang B; Xie Y; Zheng L; Zheng X; Gao J; Liu X; Yuan Y; Li Z; Lu N; Xue L
BMC Gastroenterol; 2021 Oct; 21(1):408. PubMed ID: 34706681
[TBL] [Abstract][Full Text] [Related]
17. Preliminary study on the clinical and pathological relevance of gastric hepatoid adenocarcinoma.
Gao YB; Zhang DF; Jin XL; Xiao JC
J Dig Dis; 2007 Feb; 8(1):23-8. PubMed ID: 17261131
[TBL] [Abstract][Full Text] [Related]
18. Alpha-fetoprotein-producing esophageal adenocarcinoma: a mimicker of hepatocellular carcinoma.
Wang J; Liu W; Parikh K; Post AB
Clin J Gastroenterol; 2017 Feb; 10(1):7-12. PubMed ID: 27995468
[TBL] [Abstract][Full Text] [Related]
19. The potential for the development of liver metastasis from alpha-fetoprotein-producing human gastric carcinomas in nude mice.
Sawada H; Nakatani K; Watanabe A; Nishiwada T; Okumura T; Yamada Y; Yano T; Shino Y; Yamada T; Tanase M
Jpn J Clin Oncol; 1992 Oct; 22(5):303-7. PubMed ID: 1281894
[TBL] [Abstract][Full Text] [Related]
20. Solitary AFP- and PIVKA-II-producing hepatoid gastric cancer with giant lymph node metastasis.
Iso Y; Sawada T; Shimoda M; Rokkaku K; Ohkura Y; Kubota K
Hepatogastroenterology; 2005; 52(66):1930-2. PubMed ID: 16334809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
